LIFECORE BIOMEDICAL, INC. Disposal Group, Including Discontinued Operation, Other Liabilities, Current
LIFECORE BIOMEDICAL, INC. (LFCR) had Disposal Group, Including Discontinued Operation, Other Liabilities, Current of $0 as of 2022-05-29, per its 10-K/A filed 2023-03-16.
Discontinued › Notes
us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities · last filed 2023-03-16
- 2022-05-29: Disposal Group, Including Discontinued Operation, Other Liabilities, Current $0.00.
- 2021-05-30: Disposal Group, Including Discontinued Operation, Other Liabilities, Current $42.64M.
- 2020-05-31: Disposal Group, Including Discontinued Operation, Other Liabilities, Current $0.00.
- 2020-02-23: Disposal Group, Including Discontinued Operation, Other Liabilities, Current $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Other Liabilities, Current |
|---|---|
| 2022-05-29 | $0.00 10-K/A · filed 2023-03-16 |
| 2021-05-30 | $42.64M 10-K/A · filed 2023-03-16 |
| 2020-05-31 | $0.00 10-K · filed 2020-08-14 |
| 2020-02-23 | $0.00 10-Q · filed 2020-04-03 |
| 2019-11-24 | $0.00 10-Q · filed 2020-01-02 |
| 2019-08-25 | $0.00 10-Q · filed 2019-10-03 |
| 2019-05-26 | $65.00K 10-K · filed 2020-08-14 |
| 2019-02-24 | $0.00 10-Q · filed 2019-04-04 |
| 2018-05-27 | $458.00K 10-K · filed 2019-08-01 |
| 2017-05-28 | $2.13M 10-K · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |